Mechanisms of Antifungal Drug Resistance

Cowen, Leah E., Sanglard, Dominique, Howard, Susan J., Rogers, P. David, Perlin, David S.·2015·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a019752

Cites (222)

Items 201–222 of 222

  1. Relationships between Respiration and Susceptibility to Azole Antifungals in <i>Candida glabrata</i>
    Brun, Sophie, Aubry, Christophe, Lima, Osana, Filmon, Robert, Bergès, Thierry, Chabasse, Dominique, Bouchara, Jean-Philippe · 2003 · Antimicrobial Agents and Chemotherapy
  2. Transcriptional Activation of Heat Shock Protein 90 Mediated Via a Proximal Promoter Region as Trigger of Caspofungin Resistance in Aspergillus fumigatus
    Lamoth, Frédéric, Juvvadi, Praveen R., Gehrke, Christopher, Asfaw, Yohannes G., Steinbach, William J. · 2014 · The Journal of Infectious Diseases
  3. Caspofungin Dose Escalation for Invasive Candidiasis Due to Resistant Candida albicans
    Nathan P. Wiederhold, Laura K. Najvar, Rosie A. Bocanegra, William R. Kirkpatrick, Thomas F. Patterson · 2011 · Antimicrobial Agents and Chemotherapy
  4. Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent
    Elias K. Manavathu, José A. Vázquez, Pranatharthi Haran Chandrasekar · 1999 · International Journal of Antimicrobial Agents
  5. Nuclear receptor-like transcription factors in fungi
    Anders M. Näär, Jitendra K. Thakur · 2009 · Genes & Development
  6. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
    M. Martinez · 2002 · Journal of Antimicrobial Chemotherapy
  7. Transcriptional Regulation of MDR1 , Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site
    Perry J. Riggle, Carol A. Kumamoto · 2006 · Eukaryotic Cell
  8. Establishing Surrogate Markers for FluconazoleResistance in Candida albicans
    Steven Park, David S. Perlin · 2005 · Microbial Drug Resistance
  9. Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin
    J. L. Slater, Susan Julie Howard, Joanne Sharp, Joanne Goodwin, Lea Gregson, Ana Alastruey‐Izquierdo, Maiken Cavling Arendrup, Peter A. Warn, David S. Perlin, William W. Hope · 2011 · Antimicrobial Agents and Chemotherapy
  10. Differential Requirement of the Transcription Factor Mcm1 for Activation of the Candida albicans Multidrug Efflux Pump <i>MDR1</i> by Its Regulators Mrr1 and Cap1
    Mogavero, Selene, Tavanti, Arianna, Senesi, Sonia, Rogers, P. David, Morschhäuser, Joachim · 2011 · Antimicrobial Agents and Chemotherapy
  11. Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans
    Raman Manoharlal, Naseem Akhtar Gaur, Sneh Lata Panwar, Joachim Morschhäuser, Rajendra Prasad · 2008 · Antimicrobial Agents and Chemotherapy
  12. STB5 Is a Negative Regulator of Azole Resistance in Candida glabrata
    Jason A. Noble, Huei‐Fung Tsai, Sara D. Suffis, Qin Su, Timothy G. Myers, John E. Bennett · 2012 · Antimicrobial Agents and Chemotherapy
  13. An Improved Model of the Aspergillus fumigatus CYP51A Protein
    Marcin G. Fraczek, Michael John Bromley, Paul Bowyer · 2011 · Antimicrobial Agents and Chemotherapy
  14. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans
    Chia-Geun Chen, Yun-Liang Yang, Kuo‐Yun Tseng, Hsin‐I Shih, Ci‐Hong Liou, Chih-Chao Lin, Hsiu‐Jung Lo · 2009 · Fungal Genetics and Biology
  15. Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
    Kelley R. Healey, Säntosh K. Katiyar, Mariana Castanheira, Michael A. Pfaller, Thomas D. Edlind · 2011 · Antimicrobial Agents and Chemotherapy
  16. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans
    Raman Manoharlal, Jyotsna Gorantala, Monika Sharma, Dominique Sanglard, Rajendra Prasad · 2009 · Microbiology
  17. Corrigendum to “The biology and chemistry of antifungal agents: A review” [Bioorg. Med. Chem. 20 (2012) 5678–5698]
    M. K. Kathiravan, Amol B. Salake, Aparna S. Chothe · 2012 · Bioorganic & Medicinal Chemistry
  18. Fcr1p Inhibits Development of Fluconazole Resistance in Candida albicans by Abolishing CDR1 Induction
    Hui Shen, Mao‐Mao An, De Jun Wang, Zheng Quan Xu, Jundong Zhang, Ping‐Hui Gao, Yingying Cao, Yongbing Cao, Yuanying Jiang · 2007 · Biological and Pharmaceutical Bulletin
  19. Fungal echinocandin resistance
    Carol A. Munro · 2010 · F1000 Biology Reports
  20. Echinocandin-Resistant Candida: Molecular Methods and Phenotypes
    David S. Perlin · 2011 · Current Fungal Infection Reports
  21. Diagnosis of Antifungal Drug Resistance Mechanisms in Fungal Pathogens: Transcriptional Gene Regulation
    Dominique Sanglard · 2011 · Current Fungal Infection Reports
  22. Assessment of the Paradoxical Effect of Caspofungin in Therapy of Candidiasis
    Karl V. Clemons, Marife Espiritu, Rachana Parmar · 2006 · Antimicrobial Agents and Chemotherapy